Hôpital Charles-Le Moyne

Recent papers from Hôpital Charles-Le Moyne

1. Insights Into The Early Diversification of blaNDM-1 Genetic Contexts Following its Emergence in Acinetobacter species and Spread to Enterobacterales2026
2. Myocardial Infarction in a Patient With Chronic Lymphocytic Leukemia: Acalabrutinib-Related Dehoming as a Potential CulpritCureus · 2026
3. A niche construction-based approach to evolution by natural selection without reproduction—proof of concept and implicationsRoyal Society Open Science · 2026
4. Primary Thromboprophylaxis in Patients with Malignancy and Central Venous Catheters: TRIM-Line Randomized Controlled Trial—Design and RationaleThrombosis and Haemostasis · 2026
5. Comment on serum cannabinoid profiles of emergency department patients presenting with cannabinoid hyperemesis syndrome and acute cannabis intoxicationClinical Toxicology · 2026
6. Characterising reach and uptake of a national digital mental health service in the Australian community: This Way UpInternational Journal of Mental Health Systems · 2026
7. Prevalence, Trends and Patterns of ADHD Medication Use Among Children, Adolescents and Young Adults in Quebec, Canada: A Repeated Cross-Sectional Population-Based Study From 2000 to 2022: Prévalence, tendances et profils d’utilisation des médicaments pour le TDAH chez les enfants, les adolescents et les jeunes adultes au Québec (Canada) : étude populationnelle transversale répétée, 2000-2022The Canadian Journal of Psychiatry · 2026
8. Conserved protein sequence-structure signatures identify antibiotic resistance genes from the human microbiomeMicrobiome · 2026
9. Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert PerspectivesCurrent Oncology · 2026
10. Factors Associated with Waiting Time for a First Consultation in Rheumatology from a Centralized Referral SystemThe Journal of Rheumatology · 2026
11. New isolates from the 1970s to early 2000s provide insights into the evolution of Acinetobacter baumannii international clone 2 and its resistomeMicrobial Genomics · 2026
12. Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadirFuture Oncology · 2026
13. Group singing intervention among adult survivors living with cancer-related cognitive impairment: a type 2 hybrid effectiveness-implementation study in Quebec (Canada)2026
14. Nonclassic congenital adrenal hyperplasia and bilateral pheochromocytomas in a patient with a germline pathogenic MAX variantJCEM Case Reports · 2026
15. Rethinking One Health: Microbial Foundations for Ecological GovernanceBioEssays · 2026
16. Concordance between circulating tumor DNA and tissue biopsy in patients with newly diagnosed recurrent breast cancer.Journal of Clinical Oncology · 2026
17. Impactof MET amplification (amp) on telisotuzumab vedotin (Teliso-V) efficacy and safety in 2L+ non-squamous (NSQ) EGFR wild-type (WT) NSCLC with c-Met protein overexpression (OE).Journal of Clinical Oncology · 2026
18. European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomyLung Cancer · 2026
19. Sex-specific anxiety and depression multi-trajectories and associated risk factors in the Canadian Partnership for Tomorrow's Health longitudinal study.2026
20. European Analysis of Patients with Early-Stage Lung Adenocarcinoma and Invasive Pathological Features Who Underwent Lobectomy versus SegmentectomyJournal of Thoracic and Cardiovascular Surgery · 2026